3-DAA ± ribavirin achieved high 12-week sustained virologic response rates in Brazilian patients with GT1 hepatitis C virus (HCV) with bridging fibrosis or compensated cirrhosis. BOSTON, MA—For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results